UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ____________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-38986 98-1482650 (State or other jurisdiction of (I.R.S. Emp ...

hims & hers Investor Presentation February 2023 FINANCIALS Disclaimer This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes", "estimates," "anticipates," "expects," "intends," "plans," "may" "will," "likely" "potential," "projects" "predicts" " ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2022 Earnings Conference Call February 27, 2023 5:00 PM ET Company Participants Alice Lopatto - Vice President of Investor Relations Andrew Dudum - Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Ben Clark - Bank of America Daniel Grosslight - Citi Jack Wallace - Guggenheim Glen Santangelo - Jefferies Jonathan Yong - Credit Suisse Jonna Kim - Cowen George Hill - Deutsche Bank Korinne Wolfmeyer - Piper Sandler Ivan Feinseth - T ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ____________ HIMS & HERS HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 001-38986 98-1482650 (State or other jurisdiction of (I.R.S. Employer ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2022 Earnings Conference Call November 7, 2022 5:00 PM ET Company Participants Christine Greany - Managing Director, The Blueshirt Group Andrew Dudum - Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Daniel Grosslight - Citigroup Jonathan Young - Credit Suisse Korinne Wolfmeyer - Piper Sandler Michael Cherny - Bank of America Jack Wallace - Guggenheim Securities Maxi Ma - Deutsche Bank Joy Zhang - SVB Securities Operator Good ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q2 2022 Earnings Conference Call August 8, 2022 5:00 PM ET Company Participants Jay Spitzer - Senior Vice President, Investor Relations Andrew Dudum - Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Dan Grosslight - Citigroup Charlotte Kolb - Bank of America Jessica Tassan - Piper Sandler Maxi Ma - Deutsche Bank Jack Wallace - Guggenheim Securities Ivan Feinseth - Tigress Financial Joy Zhang - SVB Securities Operator Ladies and ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Jay Spitzer - Senior Vice President and Investor Relations Andrew Dudum - Co-Founder and our Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Daniel Grosslight - Citigroup Michael Cherny - Bank of America Jack Wallace - Guggenheim Jessica Tassan - Piper Sandler Operator Good afternoon. My name is Emma, and I will be your conference operator today. At this ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q4 2021 Earnings Conference Call February 22, 2022 5:00 PM ET Company Participants Jay Spitzer - Senior VP & Investor Relations Andrew Dudum - Chief Executive Officer Yemi Okupe - Chief Financial Officer Conference Call Participants Michael Cherny - Bank of America Matthew Shea - Piper Sandler Adam Heussner - Credit Suisse Daniel Grosslight - Citi Ivan Feinseth - Tigress Financial Partners Disclaimer*: This transcript is designed to be used alongside the freely available ...

2022 Financial Results Supplemental Presentation Hims & Hers Health, Inc. February 22, 2022 Disclaimer This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminology, including the words "believes," "estimates," "anticipates," "expects," "intends," "plans," "may," "will," "likely," " ...

Hims & Hers Health, Inc. (NYSE:HIMS) Q3 2021 Earnings Conference Call November 10, 2021 5:00 PM ET Company Participants Andrew Dudum - Chief Executive Officer Spencer Lee - Chief Financial Officer Conference Call Participants Adam Heussner - Credit Suisse Daniel Grosslight - Citi Jessica Tassan - Piper Sandler Operator Good afternoon and thank you for joining us today’s Conference Call to discuss Hims & Hers Health, Inc.’s Third Quarter 2021 Financial Results. Joining me on today's call are Andrew Dudum, ou ...